Skip to main content

Dr. Golub is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Golub's full profile

Already have an account?

Education & Training

  • Children's Hospital/Boston Medical Center
    Children's Hospital/Boston Medical CenterResidency, Pediatrics, 1989 - 1991
  • University of Chicago Division of the Biological Sciences The Pritzker School of Medicine
    University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1989

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1994 - 2024

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 2008
  • Investigator Howard Hughes Medical Institute

Publications & Presentations

PubMed

Journal Articles

  • Selective Gene Dependencies in MYCN-Amplified Neuroblastoma Include the Core Transcriptional Regulatory Circuitry  
    William C Hahn, Todd R Golub, A Thomas Look, Adam D Durbin, Neekesh V Dharia, Kimberly Stegmaier, Nature
  • Genetic and Transcriptional Evolution Alters Cancer Cell Line Drug Response  
    Todd R Golub, Rameen Beroukhim, Pratiti Bandopadhayay, Nature
  • Retraction Note: Selective Killing of Cancer Cells by a Small Molecule Targeting the Stress Response to ROS  
    Stuart L Schreiber, Todd R Golub, Nature
  • Join now to see all

Press Mentions

  • René Salazar Joins Broad Institute as Chief Equity Officer
    René Salazar Joins Broad Institute as Chief Equity OfficerOctober 14th, 2021
  • 40th Anniversary Recollections & Predictions
    40th Anniversary Recollections & PredictionsOctober 4th, 2021
  • Novo Nordisk Foundation, Harvard, MIT Launch Research Center with Focus on Diabetes
    Novo Nordisk Foundation, Harvard, MIT Launch Research Center with Focus on DiabetesSeptember 15th, 2021
  • Join now to see all

Grant Support

  • Broad Institute Center For Cancer Systems BiologyNational Cancer Institute2010–2012
  • Large Scale Gene Expression Analysis Of Cellular StatesNational Human Genome Research Institute2010–2011
  • Discovery Pipeline (2 Of 4)National Cancer Institute2009–2011
  • Molecular Signatures Of Melanoma: Predicting Response To Therapy &TargetingNational Cancer Institute2008–2011
  • Genomics And BioinformaticsNational Cancer Institute2007–2011
  • Connectivity MAP 100KNational Human Genome Research Institute2009–2010
  • Genomics And BioinformaticsNational Cancer Institute2006–2010
  • Anti-All Small Molecular Discovery VIA Chemical GenomicsNational Cancer Institute2006–2010
  • Discovery Of Inhibitors Of Anti-Apoptotic Protein A1National Institute On Drug Abuse2009
  • Signatures Of Kinase Activation In CancerNational Cancer Institute2004–2009
  • Discovery Pipeline (2 Of 4)National Cancer Institute2007–2008
  • Functional Genomic Dissection Of Refractory AnemiaNational Heart, Lung, And Blood Institute2005–2007
  • Genomic Expression Analysis Of Tumors After Radical ProstatectomyNational Cancer Institute2002
  • Core--GenomicsNational Cancer Institute2002
  • Core--Dna Microarray And BioinformaticsNational Cancer Institute2001–2002
  • Genomic Predictor Of Acute Lymphocytic Leukemia BiologyNational Cancer Institute2000–2002
  • Characterization Of TEL, A New Leukemogenic ETS ProteinNational Cancer Institute1997–2001
  • TEL Gene And LeukemiasNational Institute Of Diabetes And Digestive And Kidney Diseases1996–1998

Hospital Affiliations